This study delves into the crucial role of oxidative stress in non-infectious diseases and emphasizes the necessity of precise control over cellular oxidative processes using both natural and external antioxidant systems. Dysfunctions in these systems often result in various pathologies, underscoring the therapeutic promise of antioxidants in restoring cellular balance. Sílybum mariánum, known for its multifaceted biological properties such as antioxidative, hepatoprotector, anti - toxic, and organ-protective effects, emerges as a compelling subject for investigating its mechanisms, particularly in diabetes mellitus. Our research examines the impact of Sílybum mariánum's ethanolic extract on oxidative stress levels in alloxan-induced diabetic conditions. Our results demonstrate significant antioxidant effects of the extract on the heart and aorta preparations in diabetic rats. This study adds to the expanding body of research on the potential therapeutic utility of Sílybum mariánum in addressing oxidative stress-related complications linked with diabetes mellitus.
This research looks at the heart-healthy and antioxidant effects of a polyphenol mixture made from Rhus glabra by using a lot of different types of experiments. First, the DPPH assay was used to test the antiradical activity. It showed strong free radical scavenging abilities, with an IC50 value of 18.4 ± 1.4 µL. Mitochondria isolated from rat liver were utilized to examine antioxidative effects on mitochondrial K+ATP ion channels and the mitochondrial permeability transition pore (mPTP). Lipid peroxidation (LPO) was measured via malondialdehyde (MDA) production, indicating that the preparation inhibited LPO and oxidative stress in mitochondrial membranes. Further, the study employed an adrenaline-induced ischemia model to evaluate cardioprotective effects. Treatment with the polyphenol preparation significantly reduced enzyme markers such as ALT, AST, CK, and LDH compared to the ischemic group, highlighting its potential in mitigating ischemic damage. Creatine kinase activity assays indicated improved cellular energy metabolism and biochemical profiling revealed enhancements in atherogenic, cardioprotective, and coronary risk indices. Statistical analyses confirmed the significance of these findings, demonstrating that Rhus glabra exhibits potent antioxidant activity, mitigates oxidative stress, and provides cardioprotective benefits. The study's results suggest that Rhus glabra holds substantial therapeutic potential for enhancing cardiovascular health and combating oxidative stress through its antioxidant properties and ability to improve mitochondrial function and protect against ischemic injury.
This study investigates the antioxidant potential of Rhodiola.h extract using a combination of in vivo and in silico approaches. HPLC analysis was conducted to determine the phytochemical composition of the extract. In vivo assays demonstrated significant enzyme activation, with superoxide dismutase (SOD) activity increased by 63.07 ± 1.5 % and catalase activity increased by 58.7 ± 1.6 %. In addition, experiments evaluated malondialdehyde (MDA) levels, highlighting the extract’s ability to reduce lipid peroxidation. Molecular docking studies revealed strong binding affinities of epigallocatechin ( 7.09 kcal/mol), rosavin ( 6.71 kcal/mol), and salidroside ( 6.34 kcal/mol) with the Keap1 protein, a key regulator of the Nrf2 signaling pathway. Pharmacokinetic analysis showed high gastrointestinal absorption for salidroside and flavonoids, underscoring their bioavailability. These findings suggest that R. heterodonta extract holds promise for activating antioxidant response elements and mitigating oxidative stress-related damage. HIGHLIGHTS Improvement of Antioxidant System. Activation of NRF2Patway via extracts. Dual approaching in vitro and in silico. GRAPHICAL ABSTRACT
13 November 2024 in Chemistry of plant raw material
As a result of the study of antiradical and antioxidant activities under in vitro conditions, it was determined that Rutan has a high antiradical activity to the free radical DPPH, it is a verified antioxidant, the mechanism of action of which is the release of transportable hydrogen to the free radical, resulting in the chain termination of the peroxidation reaction lipids (LPO). This fact is also confirmed by the correlation coefficient r=0.94 between the manifestation of antioxidant and antiradical properties. In experiments on the ability to inhibit the opening of mPTP, it was shown that Rutan has a protective effect on mitochondrion, depending on the concentration, reducing the damaging effect of Ca2+ ions on the process of mPTP opening and is an effective regulator and modifier of the CsA-sensitive mitochondrion pore. Additionally, Rutan affects the activity of the ATP-dependent potassium channel and the enzyme-cardiomarker – creatine kinase, thereby possessing a cardioprotective mechanism and preserving the vital activity of myocardial cells.
Antihypoxic drugs are vital for protecting cells from oxygen deprivation in ischemia, stroke and heart failure. Despite their clinical potential, a unified understanding of their mechanisms and optimization strategies remains limited. This review addresses this gap by exploring how these agents interact with mitochondrial and cardiovascular ion channels to preserve cellular viability under hypoxic stress. We focus on their modulation of mitochondrial permeability transition pores (mPTP), ATP-sensitive potassium (K-ATP) channels and calcium flux through L-type and R-type channels, which are central to maintaining mitochondrial integrity and vascular function. Additionally, we examine how these compounds regulate hypoxia-inducible factor 1-alpha (HIF-1α), promote efficient electron transport and sustain redox homeostasis. Key strategies for enhancing therapeutic efficacy such as increasing lipophilicity, introducing conjugated π-systems and modifying functional groups are discussed in relation to membrane permeability and intracellular delivery. Particular emphasis is placed on the physicochemical properties that influence bilayer penetration and target specificity. Overall, this review highlights the structural and functional features that underlie the effectiveness of antihypoxic agents and provides insight into their optimization for improved clinical performance in hypoxia-related pathologies.